HEALTHJul 24 · 21:40 UTCPREMIUM TIMES NIGERIAAgency Report

CEPI begins first human trial of Bundibugyo Ebola vaccine

CEPI has initiated the first human trial of the Bundibugyo Ebola vaccine, named BD-Ebov, to assess its safety and ability to trigger immune responses in healthy adult volunteers.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

CEPIorganizationBundibugyo EbolatopicBD-Ebovtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 14 · 02:08 UTC
First human trial of Bundibugyo Ebola vaccine begins
HEALTHJul 14 · 22:31 UTC
WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola
HEALTHJun 10 · 22:24 UTC
CEPI invests $1.9m to accelerate Ebola Vaccine development
HEALTHJul 24 · 15:16 UTC
Ebola virus: first person vaccinated in UK trial of new jab
HEALTHMay 20 · 16:55 UTC
Ebola vaccine for Bundibugyo strain could take months before human trials